Table 4. Independent predictors for any revascularization.
Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age | 0.994 | 0.968–1.020 | 0.633 | 0.978 | 0.950–1.007 | 0.132 |
Male | 0.643 | 0.383–1.078 | 0.094 | 0.770 | 0.426–1.392 | 0.386 |
Diabetes | 1.847 | 1.111–3.070 | 0.018 | 1.524 | 0.897–2.592 | 0.119 |
Hypertension | 0.833 | 0.492–1.411 | 0.497 | |||
Dyslipidemia | 0.838 | 0.499–1.408 | 0.505 | |||
Current smoker | 1.259 | 0.716–2.213 | 0.424 | |||
CKD | 6.354 | 2.253–17.920 | <0.001 | 5.971 | 1.902–18.751 | 0.002 |
History of MI | 1.439 | 0.349–5.927 | 0.614 | |||
DCB angioplasty after OCT | 2.430 | 1.406–4.203 | 0.001 | |||
First-generation DES | 1.043 | 0.609–1.788 | 0.877 | |||
Homogeneous neointima | 0.301 | 0.169–0.537 | <0.001 | 0.505 | 0.222–1.150 | 0.104 |
Heterogeneous neointima | 4.324 | 2.537–7.370 | <0.001 | 2.671 | 1.261–5.656 | 0.010 |
Layered neointima | 0.820 | 0.411–1.637 | 0.574 | |||
ACEi or ARB | 0.741 | 0.417–1.316 | 0.306 | |||
Beta blocker | 0.434 | 0.251–0.752 | 0.003 | 0.745 | 0.403–1.378 | 0.348 |
Statin | 0.856 | 0.365–2.006 | 0.720 |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor antagonist; CI, confidence interval; CKD, chronic kidney disease; DCB, drug-coated balloon; DES, drug-eluting stent; MI, myocardial infarction; OCT, optical coherence tomography; HR, hazard ratio